A– Cooperative Studies Site monitoring and auditing for VA medical studies.
Notice Type: Sources Sought Notice
Posted Date:
Office Address:
Subject: A-- Cooperative Studies Site monitoring and auditing for
Classification Code: A - Research & Development
Solicitation Number: 36C24E18R0001
Contact: Contracting Officer:
Description:
VA Service Area Organization East
VA Service Area Organization East
Sources Sought NotificationCooperative Studies Monitoring Services
This Sources Sought is being issued in accordance with Federal Acquisition Regulation Part 10, Market Research. It is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the
The purpose of this Sources Sought Notice is to determine the availability and capability of qualified small businesses (including Small Business Administration Certified 8(a) companies; firms in Historically Underutilized Business Zones (HUBZone); Service-Disabled Veteran-Owned small businesses; and Women-Owned small businesses); though the
The VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (CSPCRPCC) conducts clinical studies at
The required visits/services shall include the following information from the Performance Work Statement:
CRQAs will have access to PHI/PII data during performance.
CRQAs shall meet the minimum requirements:
Qualifications/Technical Abilities/Capabilities:
Degree/Professional Certifications required:
Bachelor s Degree or Licensed Health Care Professional
Five years or more clinical research monitoring experience
Technical
Software knowledge in Microsoft Office products (Word, PowerPoint, Excel, etc.)
Task 1 Visits (with pre and post work)
Subtask 1 Site Initiation Visits - one to three days
The CRQA shall conduct site initiation visits. The vendor shall perform an evaluation of a minimum of the following, as relevant to the design of the trial:
Protocol procedures including inclusion/exclusion criteria
Subject informed consent process
Screening procedure
Randomization procedure
Investigational Product Accountability
Unanticipated Adverse Event reporting and Serious Adverse Event Reports
Source document requirements and availability
Case Report Form (CRF) completion, correction, QA procedures
Regulatory and other study document completion and maintenance
Site correspondence with sponsor, CRQA and maintenance
Other related protocol procedures
The CRQA shall assure the following regulatory information is present in the site files:
Current IRB approval protocol/amendments
Current IRB approval consents(s)
Current IRB membership list or documentation of IRB compliance
Investigator agreements
Financial disclosures
Investigator curriculum vitae (CV)
Research and indemnity (if applicable) agreement
All training requirements GCP, Health Insurance Portability and Accountability Act (HIPAA) and Human Subjects Protections (HSP)
Additionally, the CRQA shall ensure the following Study Management Documents are completed (if applicable) and appropriately filed:
Delegation of Authority Form or CRF Authorization Log
IRB policy and procedures (i.e., adverse event and protocol deviation reporting)
IRB correspondence
Sponsor correspondence
Study contact list
Subject list
Site Visit Log
CRFs (all versions)
CVs
Medical license(s)
Subtask 2 Conduct routine CRQA visit for assigned site - one to four days
When conducting a routine visit, the CRQA shall perform the following evaluations, if appropriate:
Notify the Lead CRQA and SMART of recurrent and/or serious compliance deficiencies immediately of becoming aware of such deficiencies
Check for protocol compliance
Review Essential Document Binder
Conduct subject data review
Verify CRF data against Source Documents
Review timeliness of Query resolution
Review Source Documents for Adverse Events (AE)/Serious Adverse Events (SAE)
Review CRFs for accuracy and legibility
Check for CRF submission to Data Coordinating Center
Perform investigational product accountability
Determine follow-up actions to be taken
Provide relevant GCP Training
Hold exit interview with study team to discuss site status
Assist during and after the visit as necessary with development and implementation of Corrective Actions and/or Preventive Actions (CAPAs) to mitigate recurrence of compliance deficiency
Subtask 3 Conduct study final visit for assigned site - one to four days
The CRQA shall conduct study final visits. Timing of final visit shall be directed by the SMART Chief, Monitoring. During the visit the CRQA shall:
Discuss site close-out procedures with staff
Ensure submission of data and query resolution
Review Essential Document Binder for completeness
Check for final disposition of investigational product
Retrieve documents for Sponsor files
Discuss record retention with investigator
Subtask 4 - Prepare site visit reports and summary letters
Within seven (7) calendar days after completing site visit, the CRQA shall:
Complete site visit report and prepare a follow-up Quality Assurance (QA) summary letter, if applicable, that includes:
Date(s) of visit
Identification of person(s) participating during the visit
QA activities performed
Summary of findings, conclusions, and any actions taken or planned to correct any deficiencies noted during the visit
Directed CAPA deficiencies
Subtask 5 Additional notes about preparing and conducting site visits
Scheduling The CRQA shall schedule all site visits through the SMART Manager.
Special Requirements The CRQA s reporting requirements will necessitate computer program access and literacy in Microsoft Office Programs, e.g., Word, Excel, PowerPoint, SharePoint as well as Internet capability to transmit documents and access email and correspondence. The CRQA shall provide all equipment and supplies necessary to perform the contract requirements set forth in the Request for Proposal (RFP) except for a laptop computer which shall be provided by the Government for use in CRQA services. Computer Access shall be maintained following
Frequency of Visits The frequency and timing of CRQA visits will be determined by SMART for each site based on the following
Study Team recommendations
Subject accrual rate at the site
Total number of subjects to be enrolled at the site
Complexity of the study protocol
Data collection and record keeping proficiency at the site
Observations and corrective actions from previous monitoring visits
Preparing for Visits Prior to the Monitoring visits, the CRQA shall assemble all documents and resource materials needed to conduct the visit such as:
Tentative Agenda
Estimated time needed on site with the Site Investigator/Coordinator
Specific documents needed for review
Task 2 CRQA Visits (without pre and post work) and other trial related activities
Subtask 1 Meeting or other visits - one to four days
Kickoff Meeting
Investigator s Meeting
SMART Annual CRQA training
Other
Subtask 2 -Support other CRQAs in the conduct of visits - one to four days on site
The CRQA may support another CRQA in conducting site monitoring visits.
Task 3 GCP QA Support / Hours
Lead activities
Develop Monitoring Visit Tools and Form
Create EDB / Participant Study Binder
Review and edit Protocol and Operations Manual
Develop Monitoring Plan
Develop Source Document Plan
Review and Edit Reports from other CRQAs
Attend Sponsor Calls (e.g. Executive Committee)
Address questions from sites and Sponsors
Other activities as required
All Monitors activities
Activities supporting other CRQAs such as training/retraining or remote monitoring.
Complete required study specific training.
Complete mandatory VHA training (Privacy, HIPAA, Ethics, Information Security, GCP Training, Rules and Behavior and as assigned - to be completed prior to start
Complete SMART and CSP policies and procedure training and orientation.
Training (additional guidance)
All contractor employees and subcontractor employees requiring access to
Sources Sought Response Requirements
Responses to this notice shall include:
A short (1 page or less) narrative capability statement in response to each of the individual draft Performance Work Statement (PWS) requirements.
The response shall be by electronic method (email) and include relevant experience and other information indicating and evidencing capability to successfully meet the aforementioned requirements. Responding to this not does not guarantee any opportunity for the contract, and is only used for
Description of the company s past performance and experience with implementation of this type of service that is of a similar scope and size. And information (Government or commercial entity, contract/purchase amount, etc.) relating to each of the past performance descriptions.
Business size classification of the company under the appropriate NAICS code.
Written confirmation of registration in SAM (www.sam.gov). Offerors should be registered to be considered as a source.
For questions regarding these services required for this requirement and to submit capability statements please contact [email protected] or 412-822-3158.
Link/URL: https://www.fbo.gov/notices/39b8ced332e4d1906e69521381680624
Benign Prostatic Hyperplasia Implant System
N– NIDA VA Medical Study Site Monitoring Services
Advisor News
- When new investment trends emerge, Gen Z is most likely generation to be first in
- Could ‘plain English’ become an advisor’s secret weapon?
- IRI urges Senate action on 403(b) parity legislation
- Three estate planning ideas to protect your clients and their wealth
- What advisors must know about accessible client documents
More Advisor NewsAnnuity News
- NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
- NAIC working group pressed to accelerate annuity illustration overhaul
- State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
- Wink: Annuity sales post strong Q2, led by MYGAs and structured products
- Legacy Marketing Group partners with Malibu Life USA for annuity launch
More Annuity NewsHealth/Employee Benefits News
Life Insurance News